DK0422762T3 - Fremgangsmåde til at bedømme følsomheden af HIV-1 over for zidovudin og oligonukleotider dertil - Google Patents

Fremgangsmåde til at bedømme følsomheden af HIV-1 over for zidovudin og oligonukleotider dertil

Info

Publication number
DK0422762T3
DK0422762T3 DK90308721.1T DK90308721T DK0422762T3 DK 0422762 T3 DK0422762 T3 DK 0422762T3 DK 90308721 T DK90308721 T DK 90308721T DK 0422762 T3 DK0422762 T3 DK 0422762T3
Authority
DK
Denmark
Prior art keywords
zidovudine
hiv
oligonucleotides
assessing
sensitivity
Prior art date
Application number
DK90308721.1T
Other languages
Danish (da)
English (en)
Inventor
Brendan Alexander Larder
Sharon Dawn Symons
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10661415&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0422762(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wellcome Found filed Critical Wellcome Found
Application granted granted Critical
Publication of DK0422762T3 publication Critical patent/DK0422762T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6816—Hybridisation assays characterised by the detection means
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/974—Aids related test

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • AIDS & HIV (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
DK90308721.1T 1989-08-09 1990-08-08 Fremgangsmåde til at bedømme følsomheden af HIV-1 over for zidovudin og oligonukleotider dertil DK0422762T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898918226A GB8918226D0 (en) 1989-08-09 1989-08-09 Dna assays

Publications (1)

Publication Number Publication Date
DK0422762T3 true DK0422762T3 (da) 1995-07-24

Family

ID=10661415

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90308721.1T DK0422762T3 (da) 1989-08-09 1990-08-08 Fremgangsmåde til at bedømme følsomheden af HIV-1 over for zidovudin og oligonukleotider dertil

Country Status (12)

Country Link
US (2) US5409810A (ja)
EP (1) EP0422762B1 (ja)
JP (1) JP3105907B2 (ja)
AU (1) AU638475B2 (ja)
CA (1) CA2022942C (ja)
DE (1) DE69019795T2 (ja)
DK (1) DK0422762T3 (ja)
ES (1) ES2072983T3 (ja)
GB (1) GB8918226D0 (ja)
IE (1) IE69846B1 (ja)
NZ (1) NZ234812A (ja)
ZA (1) ZA906263B (ja)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39282E1 (en) * 1989-08-09 2006-09-12 Smithkline Beecham Corporation Nucleic acid derivatives
CA2042093C (en) * 1990-05-09 2002-12-24 Gyula Hadlaczky Cell line carrying an excess of mammalian centromeres
WO1992016180A2 (en) * 1991-03-13 1992-10-01 Siska Diagnostics, Inc. Detection of 3'-azido-3'-deoxythymidine resistance
DE4129653A1 (de) * 1991-09-06 1993-03-11 Boehringer Mannheim Gmbh Verfahren zum nachweis aehnlicher nukleinsaeuren
AU4248593A (en) * 1992-05-14 1993-12-13 Mark Holodniy Polymerase chain reaction assays for monitoring antiviral therapy
US5827648A (en) * 1995-12-13 1998-10-27 Chiron Corporation Differential hybridization for relative quantification of variant populations
EP0756639B1 (en) * 1994-04-19 1998-12-30 Stichting Centraal Laboratorium van de Bloedtransfusiedienst van het Nederlandse Rode Kruis Methods for the discrimination between syncytium inducing and non syncytium inducing variants of the human immunodeficiency virus and primers to be used in the methods
US6265152B1 (en) 1995-12-22 2001-07-24 Visible Genetics Inc. Method and kit for evaluation of HIV mutations
US6007983A (en) * 1995-12-22 1999-12-28 Visible Genetics Inc. Method and kit for evaluation of HIV mutations
WO1997027332A1 (en) 1996-01-26 1997-07-31 Innogenetics N.V. Method for detection of drug-induced mutations in the reverse transcriptase gene
US20030033617A1 (en) * 1996-04-10 2003-02-13 Gyula Hadlaczky Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
US6077697A (en) 1996-04-10 2000-06-20 Chromos Molecular Systems, Inc. Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
US20020160970A1 (en) * 1996-04-10 2002-10-31 Gyula Hadlaczky Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
US6025155A (en) * 1996-04-10 2000-02-15 Chromos Molecular Systems, Inc. Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
US6830887B2 (en) 1997-03-18 2004-12-14 Bayer Healthcare Llc Method and kit for quantitation and nucleic acid sequencing of nucleic acid analytes in a sample
JP2002518452A (ja) 1998-06-24 2002-06-25 エモリ ユニバーシティ Ｈｉｖの治療薬物の製造のための他の抗ｈｉｖ薬と組み合わせた３’−アジド−２’，３’−ジデオキシウリジンの使用
US7115584B2 (en) * 1999-01-22 2006-10-03 Emory University HIV-1 mutations selected for by β-2′,3′-didehydro-2′,3′-dideoxy-5-fluorocytidine
US7635690B2 (en) 1999-01-22 2009-12-22 Emory University HIV-1 mutations selected for by β-2′,3′-didehydro-2′,3′-dideoxy-5-fluorocytidine
US6300075B1 (en) * 1999-02-03 2001-10-09 Ortho-Clinical Diagnostics, Inc Enhancement of the specificity of nucleic acid amplification by carrier nucleic acid
US7074556B2 (en) * 1999-03-02 2006-07-11 Invitrogen Corporation cDNA synthesis improvements
ATE302287T1 (de) 1999-05-28 2005-09-15 Virco Nv Neue mutationsprofile der hiv-1 reverse transcriptase in verbindung mit phänotypischem medikamentresistenz
EP2020450B9 (en) * 2000-09-01 2011-09-14 Gen-Probe Incorporated Amplification of HIV-1 sequences for detection of sequences associated with drug-resistance mutations
ATE510908T1 (de) * 2000-09-28 2011-06-15 Bioriginal Food & Science Corp Fad5-2, mitglied der desaturase-familie und verwendungen davon
AU2631602A (en) 2000-10-20 2002-04-29 Virco Nv New mutational profiles in hiv-1 reverse transcriptase correlated with phenotypic drug resistance
WO2004003223A2 (en) 2002-07-01 2004-01-08 Tibotec Pharmaceuticals Ltd. New mutational profiles in hiv-1 reverse transcriptase correlated with phenotypic drug resistance
CA2490862A1 (en) 2002-07-01 2004-01-08 Tibotec Pharmaceuticals Ltd. Mutational profiles in hiv-1 protease correlated with phenotypic drug resistance
US6834479B2 (en) * 2002-10-03 2004-12-28 Src Innovations, Llc Bagging machine having a collapsible tunnel
KR101591986B1 (ko) * 2014-02-26 2016-02-05 연세대학교 산학협력단 압축 공기로 펼쳐지는 확공 날개를 구비한 굴착 비트
KR101796939B1 (ko) * 2016-02-19 2017-11-13 박민서 공압식 굴착 머신 및 이를 이용한 굴착공 굴착 공법

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU606043B2 (en) * 1985-03-28 1991-01-31 F. Hoffmann-La Roche Ag Detection of viruses by amplification and hybridization

Also Published As

Publication number Publication date
IE69846B1 (en) 1996-10-02
GB8918226D0 (en) 1989-09-20
AU6082890A (en) 1991-02-14
USRE37918E1 (en) 2002-12-03
IE902860A1 (en) 1991-02-27
JP3105907B2 (ja) 2000-11-06
CA2022942C (en) 1999-12-21
AU638475B2 (en) 1993-07-01
EP0422762A3 (en) 1992-08-05
ES2072983T3 (es) 1995-08-01
NZ234812A (en) 1991-09-25
DE69019795T2 (de) 1995-11-02
EP0422762B1 (en) 1995-05-31
ZA906263B (en) 1992-04-29
DE69019795D1 (de) 1995-07-06
JPH03133400A (ja) 1991-06-06
EP0422762A2 (en) 1991-04-17
CA2022942A1 (en) 1991-02-10
US5409810A (en) 1995-04-25

Similar Documents

Publication Publication Date Title
DK0422762T3 (da) Fremgangsmåde til at bedømme følsomheden af HIV-1 over for zidovudin og oligonukleotider dertil
DE69032143D1 (de) Zerstörungsfreie Prüfung von Strukturelementen
NO850909L (no) Fremgangsmaate og anordning til bruk ved detonering
BR7801477A (pt) Preparado de organossilana granulada e processo para sua obtencao
DK353378A (da) Fremgangsmaade til fr&mstilling af phosphonoacylproliner og dermed beslagtede forbindelser
NO905460L (no) Broennsonde.
DK198178A (da) Glycoprotein og fremgangsmaade til fremstilling deraf
IT1096613B (it) Composizione fluoroelastomerica e processo per la sua preparazione
DK389178A (da) Fremgangsmaade til fremstilling af xantomonasbiopolymere
DK163193C (da) Fremgangsmaade og anordning ved maaling af afstanden til et objekt
IT1084178B (it) Poli-di carbo-monofluoruro e procedimento per la sua preparazione
IT1099032B (it) Solido ceramico sagomato e procedimento per la sua fabbricazione
IT1113082B (it) Glicoproteina e processo per la sua preparazione
DK375489D0 (da) Fremgangsmaade til ikke-destruktiv vurdering af printkort
DK265888A (da) Fremgangsmaade til bestemmelse af fructosamin
DK268478A (da) Mercaptoacylamidobenzoylglycin og fremgangsmaade til fremstilling deraf
DE69025440D1 (de) Probensonde
NO176193C (no) Flyttbar bro
IT1099505B (it) A-aminometilen-b-formilaminopropionitrile e processo per la sua preparazione
IT1106131B (it) 2-guanidinometil-indolina e processo per la sua preparazione
IT1096111B (it) Insieme di pezzi per la realizzazione di arcate di ponte
DK146087D0 (da) Fluidistor til maalebrug
DK113278A (da) Komposition egnet til bestemmelse af tri-iodo-thyronin og diagnosemetode der goer brug heraf
DK154229C (da) Fremgangsmaade til bloedgloedning af staal
DK112878A (da) Jordnoeddesmoerblanding og stabilisator til anvendelse deri